Dr. Charlot is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
170 Manning Drive
HEMATOLOGY/ONCOLOGY
Chapel Hill, NC 27599Phone+1 919-445-2545Fax+1 919-966-6735
Education & Training
- Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
- Boston University Medical CenterResidency, Internal Medicine, 2004 - 2007
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2004
Certifications & Licensure
- NC State Medical License 2018 - 2025
- MA State Medical License 2006 - 2019
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Mindfulness Based Smoking Cessation Program Start of enrollment: 2016 Jul 01
Publications & Presentations
PubMed
- 19 citationsSociodemographic disparities in the management of advanced lung cancer: a narrative review.Jacob Newton Stein, M. Patricia Rivera, Ashley A. Weiner, Narjust Duma, Louise M. Henderson
Journal of Thoracic Disease. 2021-06-01 - 71 citationsIncreasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research S...Randall A Oyer, Patricia Hurley, Leigh Boehmer, Suanna Steeby Bruinooge, Kathryn Levit
Journal of Clinical Oncology. 2022-07-01 - 89 citationsClinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial.Ethan Basch, Angela M. Stover, Deborah Schrag, Arlene E. Chung, Jennifer Jansen
JCO Clinical Cancer Informatics. 2020-10-28
Press Mentions
- Rashid Awarded Grant to Develop AI Tool That Recommends Optimal Clinical Trials to Pancreatic Cancer PatientsSeptember 24th, 2024
- Modest Population-Level Increases in Survival Observed After Implementation of Immune Checkpoint Inhibitors in the Treatment of Advanced NSCLC, Particularly Among the Older PatientsFebruary 1st, 2023
- Intervention Reduces Disparities in Timing of Lung Cancer Surgery Between Black and White PatientsFebruary 14th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: